Accueil / Communiqués / The Worldwide Cell Culture Media Market to 2026 – A $1.39 Billion Opportunity, Driven by the Rising Demand for Treating Chronic Diseases in a Customized Way –

The Worldwide Cell Culture Media Market to 2026 – A $1.39 Billion Opportunity, Driven by the Rising Demand for Treating Chronic Diseases in a Customized Way –

Wednesday, January 30th 2019 at 12:24pm UTC

Culture Media Market; by Reagent Type; by Type; for Applications; and by
End-users: Global Industry Analysis, Size, Share, Growth, Trends, and
Forecast 2018 – 2026 »
report has been added to’s

The global cell culture media was valued at around USD 676 million in
the year 2017 and it is expected to reach approximately USD 1,394
million by 2026. The global cell culture media market is expected to
exhibit a CAGR of more than 8.2% between 2018 and 2026.

The major factor driving the growth of cell culture media is the rising
demand for treating chronic diseases in a customized way, which has
increased the spending for cell culture development and is anticipated
to drive the cell culture media market during the forecast period.

Moreover, raising awareness about stem cell culture and its advanced
applications in large-scale life science industries will also fuel the
growth of the market during the forecast period.

Also, the vast growth in biotechnology and pharmaceutical industrial
activities worldwide and increasing spending in clinical research in
developed as well as in developing economies is expected to drive the
market during the forecast period.

However, to handle the cell culture process skilled personnel are
required. Lack of skilled lab technicians and pharmacists in developing
economies may limit the growth of the market.

Unskilled lab technicians and pharmacists are unable to understand the
proper protocol and system for in vitro cultivation which can affect the
cell culture and its growth, resulting in the contamination of cell
culture media, issues of reproducibility, the occurrence of heavy trace
elements, and others thus posing as a challenge for the market.

Topics Covered

1. Introduction

2. Executive Summary

3. Market Dynamics

4. Competitive Landscape

5. Reagent Type Segment Analysis

6. Type Segment Analysis

7. Application Segment Analysis

8. End-User Segment Analysis

9. Regional Segment Analysis

10. Company Profiles

  • Merck
  • BD Biosciences
  • Cell Essentials
  • Quality Biological
  • Bio-Techne Corporation (Atlanta Biologicals)
  • Affymetrix
  • SIAM Bioscience
  • Novozymes
  • Thermo Fisher Scientific
  • ClonTech Laboratories (Takara Bio USA)
  • Analytical Biological Services
  • J R Scientific
  • MP Biomedicals
  • SeraCare Life Sciences
  • Stemcell Technologies
  • Lonza
  • GE Healthcare

For more information about this report visit

Laura Wood, Senior Press Manager
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
For GMT Office Hours Call +353-1-416-8900
Topics: Biotechnology

Source: Research and Markets

Voir aussi

Maverick Therapeutics to Unveil Pre-Clinical Data on Novel COBRATM Platform at American Association for Cancer Research 2019 Annual Meeting

Saturday, March 30th 2019 at 12:00pm UTC – Pre-clinical Data Characterize the Conditional and Potent …